Targeting a surface cavity of alpha 1-antitrypsin to prevent conformational disease

H Parfrey, R Mahadeva, NA Ravenhill, A Zhou, Timothy Dafforn, RC Foreman, DA Lomas

Research output: Contribution to journalArticle

58 Citations (Scopus)


Conformational diseases are caused by a structural rearrangement within a protein that results in aberrant intermolecular linkage and tissue deposition. This is typified by the polymers that form with the Z deficiency variant of alpha 1-antitrypsin (Glu-342 --> Lys). These polymers are retained within hepatocytes to form inclusions that are associated with hepatitis, cirrhosis, and hepatocellular carcinoma. We have assessed a surface hydrophobic cavity in alpha1-antitrypsin as a potential target for rational drug design in order to prevent polymer formation and the associated liver disease. The introduction of either Thr-114 --> Phe or Gly-117 --> Phe on strand 2 of beta-sheet A within this cavity significantly raised the melting temperature and retarded polymer formation. Conversely, Leu-100 --> Phe on helix D accelerated polymer formation, but this effect was abrogated by the addition of Thr-114 --> Phe. None of these mutations affected the inhibitory activity of alpha 1-antitrypsin. The importance of these observations was underscored by the finding that the Thr-114 --> Phe mutation reduced polymer formation and increased the secretion of Z alpha 1-antitrypsin from a Xenopus oocyte expression system. Moreover cysteine mutants within the hydrophobic pocket were able to bind a range of fluorophores illustrating the accessibility of the cavity to external agents. These results demonstrate the importance of this cavity as a site for drug design to ameliorate polymerization and prevent the associated conformational disease.
Original languageEnglish
Pages (from-to)33060-33066
Number of pages7
JournalJournal of Biological Chemistry
Issue number35
Early online date4 Jun 2003
Publication statusPublished - 4 Jun 2003


Dive into the research topics of 'Targeting a surface cavity of alpha 1-antitrypsin to prevent conformational disease'. Together they form a unique fingerprint.

Cite this